Patient-Specific Modeling of Diffuse Large B-Cell Lymphoma

Personalized medicine aims to tailor treatment to patients based on their individual genetic or molecular background. Especially in diseases with a large molecular heterogeneity, such as diffuse large B-cell lymphoma (DLBCL), personalized medicine has the potential to improve outcome and/or to reduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Thobe, Kirsten, Konrath, Fabian, Chapuy, Björn, Wolf, Jana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615565/
https://www.ncbi.nlm.nih.gov/pubmed/34829885
http://dx.doi.org/10.3390/biomedicines9111655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615565/
https://www.ncbi.nlm.nih.gov/pubmed/34829885
http://dx.doi.org/10.3390/biomedicines9111655

Ejemplares similares